Weiss Multi-Strategy Advisers’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-8,000
Closed -$258K 605
2016
Q4
$258K Sell
8,000
-900
-10% -$30K 0.01% 371
2016
Q3
$305K Buy
+8,900
New +$349K 0.02% 376
2015
Q4
Sell
-27,500
Closed -$1.13M 439
2015
Q3
$1.13M Buy
+27,500
New +$1.68M 0.05% 250
2015
Q2
Sell
-14,000
Closed -$1.24M 511
2015
Q1
$1.24M Sell
14,000
-2,000
-13% -$203K 0.06% 301
2014
Q4
$1.42M Buy
16,000
+4,000
+33% +$378K 0.05% 247
2014
Q3
$1.16M Sell
12,000
-3,000
-20% -$292K 0.03% 360
2014
Q2
$1.38M Buy
15,000
+5,000
+50% +$381K 0.03% 378
2014
Q1
$700K Buy
+10,000
New +$680K 0.01% 562

Other funds holding PCRX

Weiss Multi-Strategy Advisers's PCRX Position: Q1 2017 in Review

Weiss Multi-Strategy Advisers sold out of Pacira BioSciences (PCRX) in Q1 2017, closing a stake of 8,000 shares — an estimated $258K sold.

Weiss Multi-Strategy Advisers first reported a position in PCRX in Q1 2014 and held it in 8 quarters. The position peaked at $1.42M in Q4 2014. 192 funds tracked by Wall St. Rank hold PCRX as of Q1 2017.

  • Weiss Multi-Strategy Advisers reported no remaining Pacira BioSciences position as of Q1 2017 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 8,000 Pacira BioSciences shares in Q1 2017, an estimated $258K.
  • Weiss Multi-Strategy Advisers first reported a position in Pacira BioSciences in Q1 2014 and held it in 8 quarters.
  • Weiss Multi-Strategy Advisers's Pacira BioSciences position peaked at $1.42M in Q4 2014.
  • 192 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2017, filed 15 May 2017.